假性缺氧与炎症对长期腹膜透析患者腹膜改变的相对贡献
本综述检视腹膜透析中腹膜炎症的证据,提出高糖诱导的假性缺氧新假说:葡萄糖代谢使NADH-NAD+比值升高,上调缺氧诱导因子-1基因,进而激活葡萄糖转运体-1及TGFβ、血管内皮生长因子、纤溶酶原激活物抑制剂-1、结缔组织生长因子等促纤维化基因。减少腹膜暴露于过高透析液葡萄糖负荷是避免假性缺氧所致改变的核心措施,可通过使用艾考糊精或低分子质量渗透剂低剂量组合部分实现;在透析液中添加丙氨酰谷氨酰胺需进一步临床研究。
要点
- 假性缺氧指过量葡萄糖代谢致胞质NADH-NAD+比值升高,类似缺氧的高NADH-NAD+比值状态。
- 葡萄糖诱导的高NADH-NAD+比值上调缺氧诱导因子-1基因,激活葡萄糖转运体-1及多种促纤维化基因。
- 减少腹膜暴露于过高透析液葡萄糖负荷是避免假性缺氧所致改变的核心措施。
核心结论
- 当前研究提示腹膜炎症是长期腹膜透析腹膜改变的驱动力,本综述提出高糖诱导的假性缺氧新假说。
- 减少腹膜暴露于过高透析液葡萄糖负荷是避免假性缺氧所致改变的核心措施。
研究设计与样本
- 本综述检视腹膜炎症的现有证据并提出假性缺氧假说,原文未报告检索范围。
主要发现
- 长期腹膜透析与腹膜功能改变相关,如高小分子溶质转运率的发生和超滤受损。
- 形态学改变可发生,最突出的是间皮丢失、血管病变和间质纤维化。
- 假性缺氧时过量葡萄糖代谢致胞质NADH-NAD+比值升高,上调缺氧诱导因子-1基因。
- 缺氧诱导因子-1基因刺激葡萄糖转运体-1基因及TGFβ、血管内皮生长因子、纤溶酶原激活物抑制剂-1、结缔组织生长因子等促纤维化基因。
关键数值与推荐
- 减少腹膜暴露于过高透析液葡萄糖负荷可部分通过使用艾考糊精或低分子质量渗透剂低剂量组合实现。
- 在透析液中添加丙氨酰谷氨酰胺需进一步临床研究。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Long-term peritoneal dialysis is associated with alterations in peritoneal function, like the development of high small solute transfer rates and impaired ultrafiltration. Also, morphologic changes can develop, the most prominent being loss of mesothelium, vasculopathy, and interstitial fibrosis. Current research suggests peritoneal inflammation as the driving force for these alterations. In this review, the available evidence for inflammation is examined and a new hypothesis is put forward consisting of high glucose-induced pseudohypoxia. Hypoxia of cells is characterized by a high (oxidized-reduced nicotinamide dinucleotide ratio) NADH-NAD+ ratio in their cytosol. Pseudohypoxia is similar but occurs when excessive amounts of glucose are metabolized, as is the case for peritoneal interstitial cells in peritoneal dialysis. The glucose-induced high NADH-NAD+ ratio upregulates the hypoxia-inducible factor-1 gene, which stimulates not only the glucose transporter-1 gene but also many profibrotic genes like TGFβ, vascular endothelial growth factor, plasminogen activator inhibitor-1, and connective tissue growth factor, all known to be involved in the development of peritoneal fibrosis. This review discusses the causes and consequences of pseudohypoxia in peritoneal dialysis and the available options for treatment and prevention. Reducing peritoneal exposure to the excessively high dialysate glucose load is the cornerstone to avoid the pseudohypoxia-induced alterations. This can partly be done by the use of icodextrin or by combinations of low molecular mass osmotic agents, all in a low dose. The addition of alanyl-glutamine to the dialysis solution needs further clinical investigation.
引用
- Krediet RT, Parikova A. Relative Contributions of Pseudohypoxia and Inflammation to Peritoneal Alterations with Long-Term Peritoneal Dialysis Patients. Clin J Am Soc Nephrol. 2022. PMID: 35168992. doi:10.2215/CJN.15371121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。